252 related articles for article (PubMed ID: 18440958)
1. Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases.
Kumar R; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
QJM; 2008 Jun; 101(6):479-85. PubMed ID: 18440958
[TBL] [Abstract][Full Text] [Related]
2. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
3. The natural history of chronic hepatitis B: a retrospective study.
Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
[TBL] [Abstract][Full Text] [Related]
4. Clinical features in hepatocellular carcinoma and the impact of autopsy on diagnosis. A study of 530 cases from a low-endemicity area.
Kaczynski J; Hansson G; Wallerstedt S
Hepatogastroenterology; 2005; 52(66):1798-802. PubMed ID: 16334780
[TBL] [Abstract][Full Text] [Related]
5. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Nguyen VT; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
[TBL] [Abstract][Full Text] [Related]
6. Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis.
Arrieta O; Rodriguez-Diaz JL; Rosas-Camargo V; Morales-Espinosa D; Ponce de Leon S; Kershenobich D; Leon-Rodriguez E
Cancer; 2006 Oct; 107(8):1852-8. PubMed ID: 16967451
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of hepatocellular carcinoma with extrahepatic metastases.
Natsuizaka M; Omura T; Akaike T; Kuwata Y; Yamazaki K; Sato T; Karino Y; Toyota J; Suga T; Asaka M
J Gastroenterol Hepatol; 2005 Nov; 20(11):1781-7. PubMed ID: 16246200
[TBL] [Abstract][Full Text] [Related]
8. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
[TBL] [Abstract][Full Text] [Related]
9. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
Trevisani F; Magini G; Santi V; Morselli-Labate AM; Cantarini MC; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
Am J Gastroenterol; 2007 May; 102(5):1022-31. PubMed ID: 17313497
[TBL] [Abstract][Full Text] [Related]
10. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
Schott E; Bergk A; Berg T
Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
[TBL] [Abstract][Full Text] [Related]
11. Viral hepatitis and hepatocellular carcinoma.
Marrero CR; Marrero JA
Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence.
Moore SW; Millar AJ; Hadley GP; Ionescu G; Kruger M; Poole J; Stones D; Wainwright L; Chitnis M; Wessels G
Cancer; 2004 Aug; 101(3):642-9. PubMed ID: 15274079
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR
J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study.
Alacacioglu A; Somali I; Simsek I; Astarcioglu I; Ozkan M; Camci C; Alkis N; Karaoglu A; Tarhan O; Unek T; Yilmaz U
Jpn J Clin Oncol; 2008 Oct; 38(10):683-8. PubMed ID: 18753360
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of a cohort of 63 patients with hepatocellular carcinoma treated with octreotide.
Rabe C; Pilz T; Allgaier HP; Halm U; Strasser C; Wettstein M; Sauerbruch T; Caselmann WH
Z Gastroenterol; 2002 Jun; 40(6):395-400. PubMed ID: 12055662
[TBL] [Abstract][Full Text] [Related]
17. Kentucky hepatoma: epidemiologic variant or same problem in a different region?
Martin RC; Loehle J; Scoggins CR; McMasters KM
Arch Surg; 2007 May; 142(5):431-6; discussion 436-7. PubMed ID: 17515484
[TBL] [Abstract][Full Text] [Related]
18. [Prevention of cirrhosis is the best measure against hepatocellular cancer].
Kaczynski J
Lakartidningen; 1999 Jan; 96(4):338-41. PubMed ID: 10024824
[TBL] [Abstract][Full Text] [Related]
19. Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Kim BK; Han KH; Ahn SH
Oncology; 2011; 81 Suppl 1():41-9. PubMed ID: 22212935
[TBL] [Abstract][Full Text] [Related]
20. [Hepatocellular carcinoma. Experience at the Instituto Nacional de Cancerología].
Mondragón Sánchez R; Ochoa Carrillo FJ; Ruiz Molina JM; Herrera Goepfer R; Oñate Ocaña LF; Aiello Crocifoglio V
Rev Gastroenterol Mex; 1997; 62(1):34-40. PubMed ID: 9190651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
